Nuclear factor erythroid 2-related factor 2 as targets to treat chronic obstructive pulmonary disease: toward new perspectives
Therapeutic Advances in Respiratory Disease
Published online on August 17, 2026
Abstract
Therapeutic Advances in Respiratory Disease, Volume 20, January-December 2026.
Chronic obstructive pulmonary disease (COPD) is a common respiratory disease characterized by persistent airflow limitation and driven by interconnected pathways of oxidative stress, inflammation, and cell death. While nuclear factor E2-related factor 2 (...
Chronic obstructive pulmonary disease (COPD) is a common respiratory disease characterized by persistent airflow limitation and driven by interconnected pathways of oxidative stress, inflammation, and cell death. While nuclear factor E2-related factor 2 (...